• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Practical Considerations for the Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Heart Failure.心力衰竭中使用钠-葡萄糖协同转运蛋白2抑制剂的实际考量
Circ Heart Fail. 2020 Feb;13(2):e006623. doi: 10.1161/CIRCHEARTFAILURE.119.006623. Epub 2020 Feb 14.
2
The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Is Placebo Assignment Justified in Patients With Comorbid Diabetes Mellitus and Heart Failure?使用钠-葡萄糖协同转运蛋白2抑制剂进行心力衰竭临床试验的伦理问题：对于合并糖尿病和心力衰竭的患者，给予安慰剂是否合理？
Circulation. 2017 Oct 17;136(16):1459-1461. doi: 10.1161/CIRCULATIONAHA.117.029284.
3
Sodium-glucose co-transporter 2 inhibitors for the prevention of heart failure in type 2 diabetes: A systematic review and meta-analysis.钠-葡萄糖协同转运蛋白2抑制剂预防2型糖尿病患者心力衰竭：一项系统评价和荟萃分析
Eur J Prev Cardiol. 2020 Apr;27(6):667-670. doi: 10.1177/2047487319841936. Epub 2019 Apr 9.
4
Resistance to Diuretics in Heart Failure: Any Role for Empagliflozin?心力衰竭中利尿剂抵抗：恩格列净有作用吗？
Curr Vasc Pharmacol. 2019;17(4):421-424. doi: 10.2174/1570161116666180831124717.
5
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.心力衰竭风险分层与钠-葡萄糖共转运蛋白 2 抑制剂在 2 型糖尿病患者中的疗效。
Circulation. 2019 Nov 5;140(19):1569-1577. doi: 10.1161/CIRCULATIONAHA.119.042685. Epub 2019 Aug 31.
6
Cost-Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in China: A New Pillar in Our Pockets, but at What Price?钠-葡萄糖协同转运蛋白2抑制剂在中国心力衰竭患者中的成本效益：我们口袋里的新支柱，但代价几何？
J Cardiovasc Pharmacol. 2024 Jan 1;83(1):43-45. doi: 10.1097/FJC.0000000000001498.
7
Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.2型糖尿病患者心力衰竭的一级预防
Circulation. 2019 Jan 8;139(2):152-154. doi: 10.1161/CIRCULATIONAHA.118.037599.
8
Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis.在基层医疗中为 2 型糖尿病开具钠-葡萄糖共转运蛋白 2 抑制剂：肾功能和心力衰竭诊断的影响。
Cardiovasc Diabetol. 2021 Jun 28;20(1):130. doi: 10.1186/s12933-021-01316-4.
9
Importance of sodium-glucose cotransporter 2 inhibitor use in diabetic patients with acute heart failure.钠-葡萄糖协同转运蛋白2抑制剂在急性心力衰竭糖尿病患者中的应用重要性。
Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719894509. doi: 10.1177/1753944719894509.
10
Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?2型糖尿病中的钠-葡萄糖协同转运蛋白2抑制剂：一种降低心力衰竭的神奇药物？
Expert Rev Clin Pharmacol. 2019 Aug;12(8):693-695. doi: 10.1080/17512433.2019.1635453. Epub 2019 Jun 30.

引用本文的文献

1
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization.住院期间优化射血分数降低的心力衰竭的指南导向药物治疗
US Cardiol. 2021 Apr 23;15:e07. doi: 10.15420/usc.2020.29. eCollection 2021.
2
Ginseng Radix et Rhizoma enhanced the effect of metoprolol in chronic heart failure by inhibiting autophagy in male C57BL/6J mice.人参根茎通过抑制雄性 C57BL/6J 小鼠自噬增强美托洛尔在慢性心力衰竭中的作用。
PLoS One. 2024 Aug 14;19(8):e0301875. doi: 10.1371/journal.pone.0301875. eCollection 2024.
3
Effectiveness of Yiqi Fumai lyophilized injection for acute heart failure: Rationale and design of the AUGUST-AHF cohort study.益气复脉冻干注射剂治疗急性心力衰竭的有效性：AUGUST-AHF队列研究的原理与设计
Front Cardiovasc Med. 2023 Jan 10;9:1074406. doi: 10.3389/fcvm.2022.1074406. eCollection 2022.
4
Baseline Characteristics Associated With Sodium-Glucose Cotransporter Inhibitor Prescriptions in Type 2 Diabetic Patients in Jazan, Saudi Arabia.沙特阿拉伯吉赞地区2型糖尿病患者中与钠-葡萄糖协同转运蛋白抑制剂处方相关的基线特征
Cureus. 2022 Apr 19;14(4):e24284. doi: 10.7759/cureus.24284. eCollection 2022 Apr.
5
Egyptian expert opinion for the use of sodium-glucose cotransporter-2 inhibitors in patients with heart failure with reduced ejection fraction.埃及专家关于钠-葡萄糖共转运蛋白 2 抑制剂在射血分数降低的心力衰竭患者中的应用的意见。
ESC Heart Fail. 2022 Apr;9(2):800-811. doi: 10.1002/ehf2.13811. Epub 2022 Feb 3.
6
Emerging Pharmacologic Therapies for Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭的新兴药物治疗方法。
CJC Open. 2021 Feb 1;3(5):646-657. doi: 10.1016/j.cjco.2021.01.006. eCollection 2021 May.
7
What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?钠-葡萄糖共转运蛋白 2 抑制剂在心力衰竭中的突出表现是什么？
Curr Diab Rep. 2020 Oct 11;20(11):63. doi: 10.1007/s11892-020-01347-3.
8
Weighted gene co-expression network analysis to define pivotal modules and genes in diabetic heart failure.加权基因共表达网络分析定义糖尿病心力衰竭中的关键模块和基因。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20200507.

本文引用的文献

1
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者。
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
2
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会（ESC）与欧洲糖尿病研究协会（EASD）合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.
3
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.SGLT2 抑制剂预防 2 型糖尿病患者肾衰竭：系统评价和荟萃分析。
Lancet Diabetes Endocrinol. 2019 Nov;7(11):845-854. doi: 10.1016/S2213-8587(19)30256-6. Epub 2019 Sep 5.
4
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.卡格列净与 2 型糖尿病和肾病患者的肾脏结局。
N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.
5
Practical Guide to Prescribing Sodium-Glucose Cotransporter 2 Inhibitors for Cardiologists.《临床药师处方钠-葡萄糖共转运蛋白 2 抑制剂实用指南》。
JACC Heart Fail. 2019 Feb;7(2):169-172. doi: 10.1016/j.jchf.2018.11.013.
6
2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.2018年美国心脏病学会专家共识决策路径：2型糖尿病合并动脉粥样硬化性心血管疾病患者降低心血管风险的新型疗法：美国心脏病学会专家共识决策路径特别工作组报告
J Am Coll Cardiol. 2018 Dec 18;72(24):3200-3223. doi: 10.1016/j.jacc.2018.09.020. Epub 2018 Nov 26.
7
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.SGLT2 抑制剂用于 2 型糖尿病的心血管和肾脏结局的一级和二级预防：心血管结局试验的系统评价和荟萃分析。
Lancet. 2019 Jan 5;393(10166):31-39. doi: 10.1016/S0140-6736(18)32590-X. Epub 2018 Nov 10.
8
Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization.心力衰竭住院期间的起始、持续、转换和停药。
JACC Heart Fail. 2019 Jan;7(1):1-12. doi: 10.1016/j.jchf.2018.06.011. Epub 2018 Nov 7.
9
Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling.美国食品药品监督管理局扩大标签范围后SGLT2i的处方模式
J Am Coll Cardiol. 2018 Dec 25;72(25):3370-3372. doi: 10.1016/j.jacc.2018.08.2202.
10
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.射血分数降低的心力衰竭的药物治疗：CHAMP-HF 注册研究。
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366. doi: 10.1016/j.jacc.2018.04.070.

Practical Considerations for the Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Heart Failure.

作者信息

Honigberg Michael C, Vardeny Orly, Vaduganathan Muthiah

机构信息

Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA (M.C.H.).

Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care System, University of Minnesota, Minneapolis, MN (O.V.).

出版信息

Circ Heart Fail. 2020 Feb;13(2):e006623. doi: 10.1161/CIRCHEARTFAILURE.119.006623. Epub 2020 Feb 14.

DOI:10.1161/CIRCHEARTFAILURE.119.006623
PMID:32059632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7543063/
Abstract
摘要